What's happening
This bill establishes new rules and limitations for how pharmacy benefit managers can conduct audits of pharmacies in New York.
Why it matters
Creates clear procedural safeguards for pharmacies. by requiring advance, detailed notice and limiting when and how audits can be conducted, reducing operational disruptions and surprise investigations.
Protects pharmacies from punitive actions over minor, non-harmful errors. by mandating that claims retroactively denied for clerical mistakes (without evidence of fraud or financial harm) must still be paid, unless there's a demonstrated pattern or significant loss.
Limits audit scope and frequency. by capping the lookback period to 24 months, restricting the number of prescriptions that can be audited annually (except in cases of suspected fraud), and ensuring pharmacies have fair opportunities to respond to and correct audit findings.
Excludes certain types of audits from these protections. notably those involving suspected fraud, federally funded program claims, or immediate concurrent reviews without financial penalties—ensuring that oversight for serious or high-risk issues remains robust.
Albany, before your first meeting.
Every bill that moved yesterday, summarized in a sentence and ranked by impact. The Albany Scorecard follows on Sundays.
Free. Unsubscribe in one click. Want alerts on specific bills? Create an account.
Who cares
Headline styles
Set Pharmacy Audit Rules
Plain English, a few words. Used as the page title.
Sponsors
30 Co-sponsors
- John T. McDonald III
- James Skoufis
- Phil Steck
- Andrew Hevesi
- N. Nick Perry
- Jeffrey Dinowitz
- Thomas Abinanti
- Joseph Giglio
- David McDonough
- Clifford Crouch
- Edward Ra
- Michael J. Norris
- Steven Englebright
- Matthew Titone
- Kenneth Zebrowski
- Angelo J. Morinello
- Michael Montesano
- William Colton
- Ellen C. Jaffee
- Michael Blake
- Robin Schimminger
- Deborah Glick
- Richard Gottfried
- Peter Lawrence
- Jose Rivera
- Anthony D'Urso
- Brian D. Miller
- Michael Benedetto
- Yuh-Line Niou
- Sandy Galef
4 Multi-sponsors
History
- Referred to health
- Delivered to senate
- Passed assembly
- Advanced to third reading cal.694
- Reported
- Reported referred to codes
- Referred to health
- Referred to health
Companion bill
The same bill in the other chamber. A bill becomes law when one version passes both houses and the governor signs it, so either number can carry it.
Limit Pharmacy Audit Practices
In Senate Committee · Health · Sponsor Martin J. Golden
Full text
2 pagesUnderlined is new[Struck] is removedOfficial text on nysenate.gov ↗
STATE OF NEW YORK
6733
2017-2018 Regular Sessions
IN ASSEMBLY
March 16, 2017
Introduced by M. of A. LAVINE -- read once and referred to the Committee on Health
AN ACT to amend the public health law, in relation to audits of pharmacies
The People of the State of New York, represented in Senate and Assembly, do enact as follows:
Section 1. The public health law is amended by adding a new section 280-c to read as follows:
§ 280-c. Pharmacy audits by pharmacy benefit managers. 1. Definitions. As used in this section, the following terms shall have the following meanings:
(a) "Pharmacy benefit manager" shall have the same meaning as in section two hundred eighty-a of this article.
(b) "Pharmacy" shall mean a pharmacy that has contracted with a pharmacy benefit manager for the provision of pharmacy services.
2. When conducting an audit of a pharmacy's records, a pharmacy benefit manager shall:
(a) not conduct an on-site audit of a pharmacy at any time during the first three calendar days of a month;
(b) notify the pharmacy or its contracting agent no later than fifteen days before the date of initial on-site audit. Such notification to the pharmacy or its contracting agent shall be in writing delivered either (i) by mail or common carrier, return receipt requested, or (ii) electronically with electronic receipt confirmation, addressed to the supervising pharmacist of record and pharmacy corporate office where applicable, at least fifteen days before the date of an initial on-site audit;
(c) limit the audit period to twenty-four months after the date a claim is submitted to or adjudicated by the pharmacy benefit manager;
(d) include in the written advance notice of an on-site audit the list of specific prescription numbers to be included in the audit that may or may not include the final two digits of the prescription numbers;
EXPLANATION--Matter in italics (underscored) is new; matter in brackets
[ ] is old law to be omitted.
LBD06021-04-7
A. 6733 2
(e) use the written and verifiable records of a hospital, physician or other authorized practitioner, which are transmitted by any means of communication, to validate the pharmacy records in accordance with state and federal law;
(f) limit the number of prescriptions audited to no more than one hundred randomly selected in a twelve-month period, except in cases of fraud;
(g) provide the pharmacy or its contracting agent with a copy of the preliminary audit report within forty-five days after the conclusion of the audit;
(h) be allowed to conduct a follow-up audit on-site if a remote or desk audit reveals the necessity for a review of additional claims;
(i) in the case of invoice audits, accept as validation invoices from any wholesaler registered with the department of education from which the pharmacy has purchased prescription drugs or, in the case of durable medical equipment or sickroom supplies, invoices from an authorized distributor other than a wholesaler;
(j) provide the pharmacy or its contracting agent with the ability to provide documentation to address a discrepancy or audit finding, provided that such documentation must be received by the pharmacy benefit manager no later than the forty-fifth day after the preliminary audit report was provided to the pharmacy or its contracting agent. The pharmacy benefit manager shall consider a reasonable request from the pharmacy for an extension of time to submit documentation to address or correct any findings in the report; and
(k) provide the pharmacy or its contracting agent with the final audit report no later than sixty days after the initial audit report was provided to the pharmacy or its contracting agent.
3. Any claim that was retroactively denied for a clerical error, typographical error, scrivener's error or computer error shall be paid if the prescription was properly and correctly dispensed, unless a pattern of such errors exists, fraudulent billing is alleged or the error results in actual financial loss to the entity. A clerical error is an error that does not result in actual financial harm to the covered entity or consumer and does not include the dispensing of an incorrect dose, amount or type of medication or dispensing a prescription drug to the wrong person.
4. This section shall not apply to:
(a) audits in which suspected fraudulent activity or other intentional or willful misrepresentation is evidenced by a physical review, review of claims data or statements, or other investigative methods; or
(b) audits of claims paid for by federally funded programs; or
(c) concurrent reviews or desk audits that occur within three business days of transmission of a claim and where no chargeback or recoupment is demanded.
§ 2. This act shall take effect on the sixtieth day after it shall have become a law.
Reflowed for reading: line numbers and page breaks removed. Cite the official text.
Summaries, headlines and scores are AI-generated from the official bill text. How we score bills. Source: NYS Open Legislation.